Form 4 for CGON CG Oncology, Inc.
Accepted 2026-01-13 00:00:00 ET · period of report 2026-01-09 · accession 0001193125-26-011756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-01-13 | 2026-01-09 | CGON | Mulay James | Dir | S - Sale+OE | $52.47 | -11.1K | 0 | -100% | -$584.8K |
| DMT | 2026-01-13 | 2026-01-09 | CGON | Mulay James | Dir | M - OptEx | $12.07 | +11.1K | 10.5K | New | +$134.5K |
| DMT | 2026-01-13 | 2026-01-09 | CGON | Mulay James | Dir | M - OptEx | $0.00 | -11.1K | 1,308 | -89% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-09 | S | D | 10,491 | $52.99 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-09 | S | D | 654 | $44.16 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-09 | M | A | 654 | $3.72 | 654 | D | — | — | |
| 4 | Common | Common Stock | 2026-01-09 | M | A | 10,491 | $12.59 | 10,491 | D | — | — | |
| 5 | Derivative | Director Stock Option (right to buy) | 2026-01-09 | M | D | 10,491 | $0.00 | 5,240 | D | $12.59 · — to 2033-12-12 | 10,491 Common Stock | (F3) The stock option vests in 36 substantially equal monthly installments beginning on January 13, 2024. |
| 6 | Derivative | Director Stock Option (right to buy) | 2026-01-09 | M | D | 654 | $0.00 | 1,308 | D | $3.72 · — to 2033-06-13 | 654 Common Stock | (F2) The stock option vests in 36 substantially equal monthly installments beginning on July 14, 2023. |